DEFINITIONS
This paper is concerned with the cancer mortality trend of the stages I-IV of carcinoma of the cervix uteri. By mortality trend we mean the successive accumulation of deaths, specifically cancer deaths, during the first five years after treatment. By cancer death we mean the demise of a patient in whom cancer of the cervix was present. By intercurrent death we mean that at the time of death a former patient of carcinoma of the cervix was not known to harbor that tumor. The relative youth of most patients with carcinoma of the cervix uteri prevents the accumulation of many deaths due to intercurrent disease.
TREATMENT
Primary treatment of carcinoma of the cervix is intracavitary radium application but a very important adjunct to it is external irradiation. Most of our patients have been treated with a combination of both. The intensity of radium therapy began to increase at the end of the [1941] [1942] [1943] [1944] [1945] [1946] [1947] [1948] [1949] [1950] decade. This intensification of the treatment was gradual so that no date can be chosen that separates in this respect one treatment period from another. External irradiation, on the contrary, changed abruptly when Cobalt 60 radiation became available in 1956. The tumor dose that can be delivered with this type of radiation is much higher than with the previously employed deep X-ray therapy and the complications are fewer. The combination of higher intensity radium treatment and improved external irradiation is clearly marked in our experience by more favorable 5-yr survival rates. Our material can thereby be divided into two groups: (a) patients treated between 1941 through 1955 and (b) patients treated between 1956 and 1964.
CUMULATIVE MORTALITY
The distribution of cases by stage and treatment period is shown in Table 1 . It also indicates the overall crude 5-yr survival rate and for two treatment periods. The distribution of cases by age groups for the periods with different survival rates is very similar. Stage III patients have a tendency to be slightly older and this difference has been more marked during the period 1956-1964. The data on cumulative cancer mortality from carcinoma of the cervix uteri are presented in Tables 2-4 and displayed in Fig. 1 for the whole period of interest and for the two periods for which we have found different 5-yr survival rates. We do not present a comparative table for stage IV because the number of patients during the period 1956-1964 is very small. Among our cases 75 per cent of all cancer deaths from stage IV occur during the first post-treatment year and by the third post-treatment year all patients that are to die of the disease during the first 60 post-treatment months will have done so. The parallelism of the mortality trends between periods with different 5-yr survival rates indicates that the form of the mortality trend is strongly related to the stage of the disease.
REVIEW OF THE MEDICAL LITERATURE
Our finding that each stage of carcinoma of the cervix uteri is endowed with its own mortality trend is supported by review of the medical literature. We have tabulated mortality data from several sources and we have divided them into two groups. Table 5 presents the cumulative cancer mortality from two institutions that report results of treatment in the period 1922-1934 [2, 31. Table 6 presents cumulative cancer mortality from various sources [2, 4-61 among cases treated between 1932 and 1954 and compares them with our own results. The tables have been assembled from explicit information offered by the authors except in the case of Manchester [4] whose data have been read out of graphs adjusted for age. The first-year mortality in stage III from Manchester is distinctly out of step with the rest. However, from the second year on, the mortality trend is in line with the data from the other institutions. We have omitted the data for stage I from Sheffield because the number of deaths was small.
In Table 7 we have pooled all the data from Table 6 , added stage IV data and obtained general mortality trends.
Slight variations are present in the mortality trends as reported from various sources. However the differences between stages are so great that they overshadow the disparities within a stage among several institutions. The steadiness of stage II is notable. In stage III we find the discordant note of the first year mortality from Manchester. This displacement towards earlier death was not kept after the second year for the mortality for the second, third, fourth and fifth years is concordant with the rest.
The group of cases in stage I reported by Sorensen (Table 5 , second column) behaves in a manner very different from that of all other sources. When the survival of this group of cases is plotted on logarithmic probabilistic paper as Boag suggested [7] it does not follow a straight line. The survival has been plotted by bimesters and as having been registered midway in the 2 month period except for the deaths occurring after 5 yr. The latter have been plotted whenever they took place.
The resemblance of these curves to those of cell survival after irradiation is uncanny. It will be noted that the straight portion of the regression line does not cross the ordinate at level 1.00 in stages I-III. The displacement of the straight segment of the curves towards the right is present in systems in which, it is postulated, there is a redundancy of targets where death occurs, according to this view, when several targets are neutralized either simultaneously or consecutively. When the neutralization of a single target is enough to cause death the exponential regression line crosses the ordinate at level 1.00 [8] . The displacement of the straight segment towards the right indicates a multiplicity of targets. An index of this multiplicity is the extrapolation number. The latter is obtained by extrapolating back the straight segment of the curve and reading the value of its intersection with the ordinate.
Because of the displacement of the regression line towards the right a simple exponential would not fit the data for stages I-III. The equation S=l-(1-e-k') does. S is the proportion of doomed survivors alive at a given time t, e is the base of natural logarithms and k is a constant identical in function with a decay constant. Note that the expression (l-eekt) indicating the proportion of patients dead at time t is raised to a power n (the extrapolation number), in order to take into account the displacement of the curve towards the right.
The curves of Figs. 2 and 3 have been fitted by sight. The constant k has the dimensions months-'. It has been obtained by dividing 0.693 by the half lethality period, the latter being read out directly from the graphs.
The information available regarding the trend of mortality during the first posttreatment year is scanty. We have compared our data with Sorensen's [3] and the fit is extremely close for stages II-IV. Sorensen's stage I, as can be seen in table 5, behaves erratically. Besides the presence of the extrapolation number the curves for each stage show singular slopes. The difference in slope between stages I and II, if it exists at all, is small but it is clear that the early and late stages are differentiated by widely different slopes. The data of Table 7 follow the exponential regression lines very well when the proportion of patients dead by the 5th yr is assumed to be equivalent to the expected proportion dead according to our curves. I  I  I  I  I,  I  I  I  I  I, ,I 
DISCUSSION
We have shown that each clinical stage of carcinoma of the cervix uteri has a singular trend of mortality and that the form of the trend is independent of 5 yr survival rates. We have defined each stage in terms of an exponential function and we have found evidence of the medical literature that supports the view that the trends as described have validity beyond the experience of the University of Michigan.
We have noted a similarity between the survival of failures of treatment and the cell survival curves of radiobiology. We may postulate that tumors have to grow along the axis of time until they reach such size after which death becomes exponential [9] . The extrapolation number is greatest in stage I and reaches unity in stage IV. Another feature of interest is that the slope for the survival of doomed cases is greatest for the advanced cases and less steep for earlier ones. Myers et al [lo] have shown that in carcinoma of the breast the mortality is exponential but when cases are grouped according to the presence and absence of favorable prognostic signs the slope of the line of regression varies. The slope is steeper in the groups containing more unfavorable prognostic signs.
Another observation of interest is that cases of carcinoma of the cervix that are not cured are not grossly affected by treatment. Despite great improvements in the 5-yr survival rate the sequence of death has not shown major change. This finding though upsetting to the intuition cannot be overlooked. A more successful treatment does not thereby imply greater palliation in unsuccessful cases, for we have observed trends of mortality that are steady for each stage despite variation in the 5-yr survival rate.
Boag has shown that the distribution of the logarithm of survival of treatment failures is normal. His observation has been confirmed by others [3, 111. Berg upon critically reviewing the validity of the lognormal model concluded that often the fitting of models to data is poor particularly in the early post-treatment period. He mentions that the exponential model shows considerable deviation from the actuality of mortality. We have pointed out earlier that no simple exponential will fit the data when the curve is displaced towards the right (when the curve has a shoulder). The extrapolation number together with variations in slope are characteristics of the stages of carcinoma of the cervix uteri. Upon the framework of exponential attrition of the non-cured population other attrition forces superimpose themselves on the remaining cured population [13] . The result is a general survival curve of greater complexity than a simple exponential.
